Position in ALKS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$21,569,600
New position
Shares Held
610,000
first reported quarter
Ownership
0.366%
of shares outstanding
% of Portfolio
1.96%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Bain Capital Life Sciences Investors, LLC holds $21,569,600 across 1 Drug Manufacturers - Specialty & Generic name. ALKS ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALKS |
Alkermes plc.
This page
|
610,000 | $21,569,600 |
All Filings in ALKS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $21,569,600 | 610,000 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||